Ares Capital Research and Development Expenses 2010-2023 | ARCC
Ares Capital annual/quarterly research and development expenses history and growth rate from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Ares Capital research and development expenses for the quarter ending December 31, 2023 were $M, a NAN% increase year-over-year.
- Ares Capital research and development expenses for the twelve months ending December 31, 2023 were $0M, a NAN% increase year-over-year.
- Ares Capital annual research and development expenses for 2023 were $0B, a NAN% decline from 2022.
- Ares Capital annual research and development expenses for 2022 were $0B, a NAN% decline from 2021.
- Ares Capital annual research and development expenses for 2021 were $0B, a NAN% decline from 2020.
| Ares Capital Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $ |
| 2014 | $ |
| 2013 | $ |
| 2012 | $ |
| 2011 | $ |
| 2010 | $ |
| 2009 | $ |
| Ares Capital Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | |
| 2010-09-30 | |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-12-31 | |
| 2009-09-30 | |
| 2009-06-30 | |
| 2009-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Finance | Finance - SBIC & Commercial | $12.714B | $2.614B |
| Ares Capital Corporation is a specialty finance company, which primarily invests in U.S. middle-market companies. The company offers customized financing solutions, ranging from senior-debt instruments to equity capital, with a focus on senior secured debt. Other major investment areas were commercial & professional services, diversified financials, and insurance services. Ares Capital is structured as a non-diversified closed-end management investment company, regulated as a business development company under the Investment Company Act of 1940. It is treated as a regulated investment company ('RIC') for income-tax purposes. To maintain its RIC status, Ares Capital must distribute the majority of its investment income. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Blackstone Secured Lending Fund (BXSL) | United States | $6.135B | 8.30 |
| FS KKR Capital (FSK) | United States | $5.565B | 6.49 |
| Main Street Capital (MAIN) | United States | $4.314B | 11.89 |
| Hercules Capital (HTGC) | United States | $3.221B | 9.41 |
| Golub Capital BDC (GBDC) | United States | $2.823B | 8.44 |
| Morgan Stanley Direct Lending Fund (MSDL) | United States | $2.073B | 8.73 |
| Goldman Sachs BDC (GSBD) | United States | $1.754B | 6.77 |
| New Mountain Finance (NMFC) | United States | $1.344B | 8.15 |
| BARINGS BDC, INC (BBDC) | United States | $1.025B | 7.99 |
| Nuveen Churchill Direct Lending (NCDL) | United States | $0.965B | 0.00 |
| Carlyle Secured Lending (CGBD) | United States | $0.907B | 8.34 |
| BLACKROCK TCP CAPITAL CORP (TCPC) | United States | $0.906B | 5.69 |
| SLR Investment (SLRC) | United States | $0.873B | 9.30 |
| Amalgamated Financial (AMAL) | United States | $0.784B | 8.48 |
| Trinity Capital (TRIN) | United States | $0.735B | 6.79 |
| Crescent Capital BDC (CCAP) | United States | $0.665B | 7.51 |
| CION Investment (CION) | United States | $0.641B | 6.02 |
| Fidus Investment (FDUS) | United States | $0.633B | 7.89 |
| Palmer Square Capital BDC (PSBD) | United States | $0.545B | 0.00 |
| Gladstone Investment (GAIN) | United States | $0.517B | 14.23 |
| Gladstone Capital (GLAD) | United States | $0.483B | 11.27 |
| PennantPark Investment (PNNT) | United States | $0.482B | 7.04 |
| Runway Growth Finance (RWAY) | United States | $0.477B | 6.24 |
| Horizon Technology Finance (HRZN) | United States | $0.413B | 6.21 |
| TriplePoint Venture Growth BDC (TPVG) | United States | $0.347B | 4.70 |
| Stellus Capital Investment (SCM) | United States | $0.342B | 7.30 |
| Saratoga Investment Corp (SAR) | United States | $0.315B | 5.60 |
| WhiteHorse Finance (WHF) | United States | $0.300B | 6.98 |
| Oxford Square Capital (OXSQ) | United States | $0.192B | 6.69 |
| Medallion Financial (MFIN) | United States | $0.181B | 3.66 |
| OFS Capital (OFS) | United States | $0.128B | 6.14 |
| PhenixFIN (PFX) | United States | $0.093B | 14.24 |
| Silver Spike Investment (SSIC) | United States | $0.070B | 13.48 |
| Advanced Medical Isotope (RDGL) | United States | $0.063B | 0.00 |
| Logan Ridge Finance (LRFC) | United States | $0.060B | 16.01 |
| Investcorp Credit Management BDC (ICMB) | United States | $0.046B | 5.45 |
| Bain Capital Specialty Finance (BCSF) | United States | $0.000B | 7.49 |
| Rand Capital (RAND) | United States | $0.000B | 11.05 |